RecruitingNCT00230620
Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families
Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families With Pulmonary Arteriovenous Malformations
Sponsor
Imperial College London
Enrollment
1,000 participants
Start Date
Dec 1, 1998
Study Type
OBSERVATIONAL
Conditions
Summary
This study will examine genes involved in the vascular dysplasia Hereditary haemorrhagic telangiectasia i(HHT)
Eligibility
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with telangiectasia, hereditary hemorrhagic. The study is currently recruiting participants at 1 location.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00230620